IgA-nefropátia: vizsgálatok itt: Olaszország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
- Where
- Bari, Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Turin
- Életkor
- 18 év and over
- People
- 347 worldwide
- Run by
- Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00 - 3. fázisTaking peopleA clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials
- Where
- Bari, Modena, Naples, Pavia, Rome, Trieste
- Életkor
- 18 év and over
- People
- 69 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-519638-22-00 · EU 2024-519638-22-00 - 2. fázisTaking peopleA Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN
- Where
- Bologna, Como, Parma, Rome
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- argenx
See details and how to joinNCT07773727 · EU 2026-525638-43-00 - 2. fázisTaking peopleA Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Where
- Brescia, Pavia, Ranica
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07146906 · EU 2024-519699-24-00 - 2. fázisTaking peoplePhase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
- Where
- Bergamo, Bologna, Pavia
- Életkor
- 18 év and over
- People
- 45 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06989359 - 3. fázisTaking peopleA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Where
- Bari, Brescia, Eboli, Milan, Modena, Parma, Piacenza, Ranica, Rozzano, Trieste, Turin
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00 - 3. fázisNot yet taking people in OlaszországAn open-label, single-arm, multicenter roll-over extension program (REP) to characterize the long-term safety and tolerability of iptacopan (LNP023) in patients who have completed a clinical trial (parent study) in the iptacopan pediatric program.
- Where
- Genoa
- Életkor
- Up to 17 év
- People
- 1
- Run by
- Novartis Pharma AG
See details and how to join2026-525677-39-00 · EU 2026-525677-39-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Bologna, Naples
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleStudy of Ravulizumab in Pediatric Participants With Primary IgAN
- Where
- Genoa, Rome, Turin
- Életkor
- 2 év to 18 év
- People
- 36 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07024563 · EU 2024-520167-13-00 - 2. fázisTaking peopleStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Where
- Bari, Genoa, Milan, Padova, Rome
- Életkor
- 1 év to 17 év
- People
- 67 worldwide
- Run by
- Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Bologna, Genova, Pavia, Piacenza
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659 - 4. fázisTaking peopleMulticentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
- Where
- Acquaviva delle Fonti, Bagno a Ripoli, Bologna, Bolzano, Brescia, Brindisi, Cagliari, Catania, Catanzaro, Chieti, Cosenza, Cuneo, Eboli, Ferrara, Florence, Foggia, Forlì, Genoa, Latina, Lecce, Lecco, Messina, Milan, Milano, Modena, Modica, Monza, Novara, Ostia Lido (Roma), Palermo, Parma, Pavia, Perugua, Pisa, Ravenna, Reggio Calabria, Reggio Emilia, Rimini, Roma, Rome, Rozzano, San Giovanni Rotondo, Turin, Udine, Viterbo, Ospedale San Giovanni di Dio, Azienda USL Toscana Sud Est -Ospedale Misericordia - Grosseto, Ospedale di Prato Santo Stefano
- Életkor
- 18 év and over
- People
- 878
- Run by
- Fondazione Schena
See details and how to joinNCT04662723 · EU 2024-517861-18-00